Status:

UNKNOWN

Safety and Efficacy of an Oral Penicillin Challenge in Low Risk Hospitalized Patients

Lead Sponsor:

Saskatchewan Health Authority - Regina Area

Conditions:

Penicillin Allergy

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Penicillin allergy is the most common drug allergy reported by patients. Approximately 10% of the population and 20% of inpatients carry a label of penicillin allergy. However, less than 5%-10% of the...

Detailed Description

Penicillin allergy is the most common drug allergy reported by patients. Approximately 10% of the population and 20% of inpatients carry a label of penicillin allergy. However, only \<5%-10% of them h...

Eligibility Criteria

Inclusion

  • Assessed to be low risk of having a penicillin allergy as per the risk stratification questionnaire
  • One of the following: i) An unknown reaction \>10 years before, ii) A type A adverse drug reaction (pharmacologically predictable drug side effect or intolerance), or iii) A history of a benign childhood rash, nonurticarial rash, or maculopapular exanthem more than 10 years ago
  • Age 18 years or older
  • Hemodynamically stable and suitable for discharge home

Exclusion

  • Declines participation in the study
  • Cognitive impairment and where a collateral history could not be obtained
  • History of anaphylaxis or angioedema attributed to a penicillin-based antibiotic
  • History of severe cutaneous adverse reactions attributed to a penicillin-based antibiotic
  • History of acute kidney injury or severe liver impairment attributed to a penicillin-based antibiotic
  • Currently taking an angiotensin-converting enzyme inhibitor, angiotensin-receptor blocker or a beta blocker
  • Hemodynamically unstable
  • History of idiopathic urticaria or idiopathic anaphylaxis
  • Currently taking an antibiotic(s) for treatment of an active infection

Key Trial Info

Start Date :

December 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2024

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT04408508

Start Date

December 1 2023

End Date

June 1 2024

Last Update

April 13 2023

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.